In line with these findings, several studies demonstrated that IL-6-STAT3 signaling led to the activation of Akt (see Figure 1), and that Akt inhibition could restore susceptibility to Treg suppression in Tcon cells from autoimmune disease patients (24, 25, 31). The gene discussed is AKT1; the disease is autoimmune disease.